The Latest Breaking News from Medicare

Kennedy's Deputy Pick Chris Klomp Faces Senate Health Panel as Democrats Aim to Test His Vaccine Views

Chris Klomp, the nominee for deputy HHS secretary, faces the Senate Health Committee after a Finance hearing. What Democrats want to ask and why it matters.

Medical Daily · Sep 16

Four in 10 Pediatricians Say Children Skipped Medical Appointments Over Immigration Fears in the Past Year

In an AAP survey, 40% of pediatricians said children missed appointments over immigration fears. What the finding means for families and child health.

Medical Daily · Sep 16

More Than 230 Health Groups Warn Medicare Remote Monitoring Vendor Limits Could Disrupt Care Starting in 2027

More than 230 health groups warn that a Medicare plan to stop paying for vendor-run remote monitoring could disrupt care for over 1 million people in 2027.

Medical Daily · Sep 16

Some Pancreatic Cancer Families Hit Insurance Delays After Rasonque Approval Closed the Drug's Free Early Access Program

FDA approval of the pancreatic cancer pill Rasonque closed its free early access program before some insurers were ready to cover it.

Medical Daily · Sep 16

Statins, Iron Pills, and Dementia Drugs Lead 24 Medication Chains Where a Side Effect May Prompt Another Prescription

A BMJ study of 2.3 million older adults in Ontario flagged 24 drug chains where a side effect may lead to another prescription. What families should ask.

Medical Daily · Sep 15

Confidential Drugmaker Deals Could Cut Projected Medicare Savings from Most-Favored-Nation Pricing by 71% to Nearly 80%

A Lancet model says confidential drugmaker deals could erase 71% to nearly 80% of projected Medicare savings from foreign drug price benchmarks.

Medical Daily · Sep 15

Appealed Prior Authorization Denials Are Often Overturned, but Reversal Rates Range from 16% to 93% by Insurer

Many insurance denials are reversed on appeal, but odds vary by plan. Learn how internal appeals and external reviews work and what to do first.

Medical Daily · Sep 15

FDA Grants Breakthrough Status to a Phage Treatment for Drug Resistant Staph Bloodstream Infections Ahead of Phase 3

The FDA granted Breakthrough Therapy designation to a bacteriophage treatment for complicated staph bloodstream infections ahead of a planned Phase 3 trial.

Medical Daily · Sep 14

That Prescription Is Moving to a Different Tier Next Year — What Could It Cost?

A prescription that costs $10 or $20 today may not cost the same amount when your Medicare drug coverage resets in January. Medicare Part D...

Saving Advice · Sep 14

Trump administration moves to push AI into medical care despite concerns, and these AI agents will offer therapy and prescribe medicine

That's more than a Pandora'x box.

We Got This Covered · Sep 14